Intranasal oxytocin shows promise for treating core symptom of frontotemporal dementia
A new study led by Western researchers found frequent treatment with intranasal oxytocin—a hormone in the brain associated ...
Neurology Advisor2h
Gaps Remain in Biomedical Research in Frontotemporal Dementia
Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.
News on 62h
Documentary explores frontotemporal dementia and its impact on family
The documentary "Susan" follows a woman living with frontotemporal dementia and her advocacy for others with the disease, ...
Wendy Williams Details 'Prison'-Like Facility She's in Amid Dementia Battle
Wendy Williams, who is battling frontotemporal lobe dementia and aphasia, detailed her 'prison'-like conditions at the ...
First signs of early-onset dementia as Sue Radford reveals devastating diagnosis
Sue Radford left Britain's biggest family in shock in the latest episode of the Channel 5 show when she revealed her close ...
Nottingham Post7d
5 early warning signs of dementia that should not be ignored - including one that happens at night
Health experts have warned people to be vigilant of the early signs of dementia, which include inconspicuous issues like ...
Mena FN7d
Frontotemporal Dementia Pipeline Therapeutics, Clinical Trials Assessment, Emerging Drugs And Companies Delveinsight
Discover the latest drugs and treatment options in the Frontotemporal Dementia Pipeline. Dive into DelveInsight's comprehensive report today! @ Frontotemporal Dementia Pipeline Outlook Key ...
An ALS treatment wave is approaching, and this biotech CEO is ready to surf
Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.